Cargando…

The Effect of a Diiodothyronine Mimetic on Insulin Sensitivity in Male Cardiometabolic Patients: A Double-Blind Randomized Controlled Trial

BACKGROUND AND AIMS: Obesity and its associated cardiometabolic co-morbidities are increasing worldwide. Since thyroid hormone mimetics are capable of uncoupling the beneficial metabolic effects of thyroid hormones from their deleterious effects on heart, bone and muscle, this class of drug is consi...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Valk, Fleur, Hassing, Carlijne, Visser, Maartje, Thakkar, Purav, Mohanan, Anookh, Pathak, Kaushal, Dutt, Chaitanya, Chauthaiwale, Vijay, Ackermans, Mariette, Nederveen, Aart, Serlie, Mireille, Nieuwdorp, Max, Stroes, Erik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931609/ https://www.ncbi.nlm.nih.gov/pubmed/24586256 http://dx.doi.org/10.1371/journal.pone.0086890

Ejemplares similares

TRC120038, a Novel Dual AT(1)/ET(A) Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 Rats
por: Mohanan, Anookh, et al.
Publicado: (2011)

Hypercaloric diets with increased meal frequency, but not meal size, increase intrahepatic triglycerides: A randomized controlled trial
por: Koopman, Karin E, et al.
Publicado: (2014)

Sexual Dimorphism in Hepatic, Adipose Tissue, and Peripheral Tissue Insulin Sensitivity in Obese Humans
por: ter Horst, Kasper W., et al.
Publicado: (2015)

The effects of 3,5-diiodothyronine on energy balance
por: Goglia, Fernando
Publicado: (2015)

Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans
por: ter Horst, Kasper W., et al.
Publicado: (2017)

Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome
por: Gilijamse, Pim W., et al.
Publicado: (2020)

Carriers of Loss-of-Function Mutations in EXT Display Impaired Pancreatic Beta-Cell Reserve Due to Smaller Pancreas Volume
por: Bernelot Moens, Sophie J., et al.
Publicado: (2014)

Safety, Tolerability, and Pharmacokinetics of a Novel Mitochondrial Modulator, TRC150094, in Overweight and Obese Subjects: A Randomized Phase-I Clinical Trial
por: Joshi, Deepa, et al.
Publicado: (2021)

TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial
por: Joshi, Deepa, et al.
Publicado: (2022)

Serotonin Transporter Binding in the Diencephalon Is Reduced in Insulin-Resistant Obese Humans
por: Versteeg, Ruth I., et al.
Publicado: (2017)

Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia
por: Visser, M. E., et al.
Publicado: (2011)

The Role of the Gut Microbiota in the Gut–Brain Axis in Obesity: Mechanisms and Future Implications
por: van Son, Jamie, et al.
Publicado: (2021)

3,5-Diiodothyronine: A Novel Thyroid Hormone Metabolite and Potent Modulator of Energy Metabolism
por: Senese, Rosalba, et al.
Publicado: (2018)

Correlation of plasma metabolites with glucose and lipid fluxes in human insulin resistance
por: Hartstra, Annick V., et al.
Publicado: (2020)

The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans
por: ter Horst, Kasper W., et al.
Publicado: (2017)

A Major Role for Perifornical Orexin Neurons in the Control of Glucose Metabolism in Rats
por: Yi, Chun-Xia, et al.
Publicado: (2009)

Subthalamic nucleus stimulation does not influence basal glucose metabolism or insulin sensitivity in patients with Parkinson's disease
por: Lammers, Nicolette M., et al.
Publicado: (2014)

Administration of 3,5-diiodothyronine (3,5-T2) causes central hypothyroidism and stimulates thyroid-sensitive tissues
por: Padron, Alvaro Souto, et al.
Publicado: (2014)

Regulation of skeletal muscle mitochondrial activity by thyroid hormones: focus on the “old” triiodothyronine and the “emerging” 3,5-diiodothyronine
por: Lombardi, Assunta, et al.
Publicado: (2015)

Thresholds for Arterial Wall Inflammation Quantified by (18)F-FDG PET Imaging: Implications for Vascular Interventional Studies
por: van der Valk, Fleur M., et al.
Publicado: (2016)

Maternal 3,3’-Diiodothyronine Sulfate Formation from Guinea Pig Placenta Perfused with 3,3’,5-Triodothyronine
por: Wu, Sing-yung, et al.
Publicado: (2021)

Striatal dopamine receptor binding in morbidly obese women before and after gastric bypass surgery and its relationship with insulin sensitivity
por: de Weijer, Barbara A., et al.
Publicado: (2014)

The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well‐controlled plasma LDL cholesterol
por: Bouter, Kristien E. C., et al.
Publicado: (2020)

Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Glucose Production via the Hepatic Sympathetic Innervation in Rats
por: Yi, Chun-Xia, et al.
Publicado: (2010)

A Thyroid Hormone-Independent Molecular Fingerprint of 3,5-Diiodothyronine Suggests a Strong Relationship with Coffee Metabolism in Humans
por: Pietzner, Maik, et al.
Publicado: (2019)

Infusion of donor feces affects the gut–brain axis in humans with metabolic syndrome
por: Hartstra, Annick V., et al.
Publicado: (2020)

Dietary saturated fat/cholesterol, but not unsaturated fat or starch, induces C-reactive protein associated early atherosclerosis and ectopic fat deposition in diabetic pigs
por: Koopmans, Sietse J, et al.
Publicado: (2011)

Plasma Imidazole Propionate Is Positively Correlated with Blood Pressure in Overweight and Obese Humans
por: van Son, Jamie, et al.
Publicado: (2021)

Neuroimaging essentials in essential tremor: A systematic review
por: Sharifi, Sarvi, et al.
Publicado: (2014)

Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study
por: Bernelot Moens, Sophie J., et al.
Publicado: (2016)

Optimizing oxytocin LC-MS/MS sensitivity by choosing the right column
por: Ackermans, Mariëtte T.
Publicado: (2021)

Manual versus Automated Carotid Artery Plaque Component Segmentation in High and Lower Quality 3.0 Tesla MRI Scans
por: Smits, Loek P., et al.
Publicado: (2016)

Metabolite Profile of Treatment-Naive Metabolic Syndrome Subjects in Relation to Cardiovascular Disease Risk
por: Warmbrunn, Moritz V., et al.
Publicado: (2021)

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
por: Zambad, Shitalkumar P, et al.
Publicado: (2013)

Potential Applications of Thyroid Hormone Derivatives in Obesity and Type 2 Diabetes: Focus on 3,5-Diiodothyronine (3,5-T2) in Psammomys obesus (Fat Sand Rat) Model
por: Bouazza, Asma, et al.
Publicado: (2022)

TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
por: Zambad, Shitalkumar P, et al.
Publicado: (2011)

Therapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis
por: Gupta, Ram, et al.
Publicado: (2014)

Dynamic magnetic resonance measurements of calf muscle oxygenation and energy metabolism in peripheral artery disease
por: Bakermans, Adrianus J., et al.
Publicado: (2019)

The Clash of Two Epidemics: the Relationship Between Opioids and Glucose Metabolism
por: Koekkoek, Laura L., et al.
Publicado: (2022)

Harnessing Antibody-Mimetic Selectivity for Activation-State-Specific Targeted Degradation of Endogenous K-Ras
por: Ferguson, Fleur M.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_et3s4mkvr3rs9u9va22avrac15